Methylarsonous acid causes oxidative DNA damage in cells independent of the ability to biomethylate inorganic arsenic

Archives of Toxicology

Volumn 88, Issue 2, 2014, Pages 249-261

  Tokar, Erik J ^a   Kojima, Chikara ^a   Waalkes, Michael P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Arsenic; Cancer; Malignant transformation; Oxidative DNA damage

Indexed keywords

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ARSENIC POISONING; ARSENICALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; HUMANS; LIVER; MALE; METHYLATION; OXIDATION-REDUCTION; PROSTATE; PTEN PHOSPHOHYDROLASE; RATS; TOXICITY TESTS, CHRONIC;

EID: 84893908884     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-013-1141-2     Document Type: Article

References (58)

1. Achanzar WE, Brambila EM, Diwan BA, Webber MM, Waalkes MP (2002) Inorganic arsenite induced malignant transformation of human prostate epithelial cells. J Natl Cancer Inst 94:1888-1891
2. Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP (2005) Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol Appl Pharmacol 206:288-298
3. Bredfeldt TG, Jagadish B, Eblin KE, Mash EA, Gandolfi AJ (2006) Monomethylarsonous acid induces transformation of human bladder cells. Toxicol Appl Pharmacol 216:69-79
4. Chang C, Pan J, Wang X, Zhang Z, Chen F, Shi X (2010) Reduced reactive oxygen species-generating capacity contributes to the enhanced growth of arsenic-transformed epithelial cells. Cancer Res 70:5127-5135
5. Cui X, Li S, Shraim A, Kobayashi Y, Hayakawa T, Kanno S, Yamamoto M, Hirano S (2004) Subchronic exposure to arsenic through drinking water alters expression of cancer-related genes in rat liver. Toxicol Pathol 32:64-72
6. Di Cristofano A, Pandolfi PP (2000) The multiple roles of PTEN in tumor suppression. Cell 100:387-390
7. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458:780-783
8. Engström K, Vahter M, Mlakar SJ, Concha G, Nermell B, Raqib R, Cardozo A, Broberg K (2011) Polymorphisms in arsenic(+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism. Environ Health Perspect 119:182-188
9. Floor SL, Dumont JE, Meanhaut C, Raspe E (2012) Hallmarks of cancer: of all cancer cells, all the time? Trends Mol Med 18:509-515
10. Gomez SE, del Razo LM, Munoz Sanchez JL (2006) Induction of DNA damage by free radicals generated either by organic or inorganic arsenic (AsIII, MMAIII, and DMAIII) in cultures of B and T lymphocytes. Biol Trace Elem Res 108:115-126
11. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP dependent transporters. Nat Rev Cancer 2:48-58
12. Hanahan D, Weinberg RA (2011) The hallmarks of cancer: the next generation. Cell 44:646-674
13. Huang YC, Hung WC, Chen WT, Yu HS, Chai CY (2011) Effects of DNMT and MEK inhibitors on the expression of RECK, MMP-9, -2, uPA and VEGF in response to arsenite stimulation in human uroepithelial cells. Toxicol Lett 201:62-71
14. International Agency for Research on Cancer (IARC) (2012) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, A Review of Human Carcinogens: Arsenic, Metals, Fibres, and Dusts, Volume 100C
15. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, Nomiyama K, Hosokawa K, Sakurada K, Nakagata N, Ikeda Y, Mak TW, Suda T (2004) Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431:997-1002
16. Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283:65-87
17. Kala SV, Neely MW, Kala G, Prater CI, Atwood DW, Rice JS, Lieberman MW (2000) The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J Biol Chem 275:33404-33408
18. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:53-67
19. Kitchin KT, Conolly R (2010) Arsenic-induced carcinogenesis - oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment. Chem Res Toxicol 23:327-335
20. Klaunig JE, Wang Z, Pu X, Zhou S (2011) Oxidative stress and oxidative damage in chemical carcinogenesis. Toxicol Appl Pharmacol 254:86-99
21. Kojima C, Ramirez DC, Tokar EJ, Himeno S, Drobna Z, Styblo M, Mason RP, Waalkes MP (2009) Requirement of arsenic biomethylation for oxidative DNA damage. J Natl Cancer Inst 101:1670-1681
22. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG (2011) Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res 711:193-201
23. Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA (2003) Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 278:12029-12038
24. Leone A, Flatow U, King CR, Sandeen MA, Marguiles IMK, Liotta LA, Steeg PS (1991) Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65:25-35
25. Leslie EM, Haimeur A, Waalkes MP (2004) Arsenic transport by the human multidrug resistance protein (MRP1/ABCC1): evidence that a tri-glutathione conjugate is required. J Biol Chem 279:32700-32708
26. Li G, Lee LS, Li M, Tsao SW, Chiu JF (2011) Molecular changes during arsenic-induced cell transformation. J Cell Physiol 226:3225-3232
27. Liu J, Chen H, Miller DS, Saavedra JE, Keefer LK, Johnson DR, Klaassen CD, Waalkes MP (2001) Overexpression of glutathione S-transferase II and multidrug resistant transport proteins is associated with acquired arsenic tolerance to inorganic arsenic. Mol Pharmacol 60:302-309
28. Mass MJ, Tennant A, Roop BC, Cullen WR, Styblo M, Thomas DJ, Kligerman AD (2001) Methylated trivalent arsenic species are genotoxic. Chem Res Toxicol 14:355-361
29. McKenzie S, Kyprianou N (2006) Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance. J Cell Biochem 97:18-32
30. Ming M, He Y-Y (2012) PTEN in DNA damage repair. Cancer Lett 319:125-129
31. National Toxicology Program (NTP) (2011) 12th Report on Carcinogens, Department of Health and Human Services, Research Triangle Park, NC
32. Nesnow S, Roop BC, Lambert G, Kadiiska M, Mason RP, Cullen WR, Mass MJ (2002) DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem Res Toxicol 15:1627-1634
33. Paul DS, Harmon AW, Devesa V, Thomas DJ, Styblo M (2007) Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ Health Perspect 115:734-742
34. Pi J, Diwan BA, Sun Y, Liu J, Qu W, He Y, Styblo M, Waalkes MP (2008) Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2. Free Radic Biol Med 45:651-658
35. Ramirez DC, Mejiba SE, Mason RP (2006) Immuno-spin trapping of DNA radicals. Nat Methods 3:123-127
36. Ramirez DC, Gomez-Mejiba SE, Mason RP (2007) Immuno-spin trapping analysis of DNA radicals. Nat Protoc 2:512-522
37. Romach EH, Zhao CQ, Del Razo LM, Cebrian ME, Waalkes MP (2000) Studies on the mechanisms of arsenic-induced self tolerance developed in liver epithelial cells through continuous low-level arsenite exposure. Toxicol Sci 54:500-508
38. Schwerdtle T, Walter I, Mackiw I, Hartwig A (2003) Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis 24:967-974
39. Shimizu T, Numata T, Okada Y (2004) A role of reactive oxygen species in apoptotic activation of volume-sensitive Cl(-) channel. Proc Natl Acad Sci 101:6770-6773
40. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci 98:10869-10874
41. Stueckel TA, Lu Y, Davis ME, Wang L, Jiang BH, Holaskova I, Schafer R, Barnett JB, Rojanasakul Y (2012) Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol 261:204-216
42. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74:289-299
43. Sun Y, Kojima C, Chignell C, Mason RM, Waalkes MP (2011) Arsenic transformation predisposes human skin keratinocytes to UV-induced DNA damage yet enhances their survival apparently by diminishing oxidant response. Toxicol Appl Pharmacol 255:242-250
44. Sun Y, Tokar EJ, Waalkes MP (2012) Overabundance of putative cancer stem cells in human skin keratinocyte cells malignantly transformed by arsenic. Toxicol Sci 125:20-29
45. Thomas DJ, Li J, Waters SB, Xing W, Adair BM, Drobna Z, Devesa V, Styblo M (2007) Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp Biol Med (Maywood) 232:3-13
46. Tokar EJ, Webber MM (2005) Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells. Clin Exp Metastasis 22:275-284
47. Tokar EJ, Diwan BA, Waalkes MP (2010a) Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype. Environ Health Perspect 118:108-115
48. Tokar EJ, Benbrahim-Tallaa L, Ward JM, Lunn R, Sams RL II, Waalkes MP (2010b) Cancer in experimental animals exposed to arsenic and arsenic compounds. Crit Rev Toxicol 40:912-927
49. Tokar EJ, Qu W, Liu J, Liu W, Webber MM, Phang JM, Waalkes MP (2010c) Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst 102:638-649
50. Tokar EJ, Diwan BA, Ward JM, Delker DA, Waalkes MP (2011) Carcinogenic effects of "whole-life" exposure to inorganic arsenic in CD1 mice. Toxicol Sci 119:73-83
51. Tokar EJ, Diwan BA, Thomas DJ, Waalkes MP (2012) Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice. Arch Toxicol 86:975-982
52. Valko M, Rhodes CJ, Moncol J, Isakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40
53. Waalkes MP, Liu J, Diwan BA (2007) Transplacental arsenic carcinogenesis in mice. Toxicol Appl Pharmacol 222:271-280
54. Waalkes MP, Liu J, Germolec DR, Trempus CS, Cannon RE, Tokar EJ, Tennant RW, Ward JM, Diwan BA (2008) Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. Cancer Res 68:8278-8285
55. Wnek SM, Jensen TJ, Severson PL, Futscher BW, Gandolfi AJ (2010) Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure. Toxicol Sci 116:44-57
56. Wnek SM, Kuhlman CL, Camarillo JM, Medeiros MK, Liu KJ, Lau SS, Gandolfi JA (2011) Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells. Toxicol Appl Pharmacol 257:1-13
57. Xu Y, Tokar EJ, Sun Y, Waalkes MP (2012) Arsenic-transformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype. Environ Health Perspect 120:865-871
58. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP (1997) Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci 94:10907-10912